The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Anticoagulants are classified as high-risk medications, with their main adverse drug events (ADEs) being recurrent venous thromboembolism (VTE) and bleeding events.Postoperative colorectal cancer (CRC) patients exhibit a high probability of recurrent VTE and bleeding during anticoagulation therapy.The Medication Therapy Management (MTM) model will contribute to reducing ADEs associated with anticoagulants in CRC patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:
• Patients with histologically confirmed CRC and symptomatic or incidental VTE who received anticoagulant treatment.
• CRC patients with VTE treated with an anticoagulant for at least 3 moths.
Locations
Other Locations
China
Sixth Affiliated Hospital, Sun Yat-sen University
RECRUITING
Guangzhou
Contact Information
Primary
xiaoyan li
lixyan5@mail.sysu.edu.cn
13609066172
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2027-12-30
Participants
Target number of participants: 327
Treatments
Experimental: Intervention group patients will receive anticoagulation management via MTM model
No_intervention: Control group patients will be managed using a standard care.
Related Therapeutic Areas
Sponsors
Leads: Sixth Affiliated Hospital, Sun Yat-sen University